Huang H - Search Results

1

Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies.

Li J, Wang Q, Han Y, Jiang L, Lu S, Wang B, Qian W, Zhu M, Huang H, Qian P. Li J, et al. Among authors: huang h. J Hematol Oncol. 2023 Jun 23;16(1):65. doi: 10.1186/s13045-023-01460-2. J Hematol Oncol. 2023. PMID: 37353849 Free PMC article. Review.

2

Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation.

Hu YX, Cui Q, Liang B, Huang H. Hu YX, et al. Among authors: huang h. Biol Blood Marrow Transplant. 2011 Aug;17(8):1099-111. doi: 10.1016/j.bbmt.2011.02.013. Epub 2011 Mar 25. Biol Blood Marrow Transplant. 2011. PMID: 21440653 Free article. Review.

3

Novel agents and biomarkers for acute lymphoid leukemia.

Zhao Y, Huang H, Wei G. Zhao Y, et al. Among authors: huang h. J Hematol Oncol. 2013 Jun 18;6:40. doi: 10.1186/1756-8722-6-40. J Hematol Oncol. 2013. PMID: 23773228 Free PMC article. Review.

4

Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.

Hu K, Gu Y, Lou L, Liu L, Hu Y, Wang B, Luo Y, Shi J, Yu X, Huang H. Hu K, et al. Among authors: huang h. J Hematol Oncol. 2015 Jan 27;8:1. doi: 10.1186/s13045-014-0099-8. J Hematol Oncol. 2015. PMID: 25622682 Free PMC article.

5

Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies.

Zhu N, Xiao H, Wang LM, Fu S, Zhao C, Huang H. Zhu N, et al. Among authors: huang h. Future Oncol. 2015;11(4):659-73. doi: 10.2217/fon.14.280. Future Oncol. 2015. PMID: 25686120 Review.

6

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy.

Hu Y, Sun J, Wu Z, Yu J, Cui Q, Pu C, Liang B, Luo Y, Shi J, Jin A, Xiao L, Huang H. Hu Y, et al. Among authors: huang h. J Hematol Oncol. 2016 Aug 15;9(1):70. doi: 10.1186/s13045-016-0299-5. J Hematol Oncol. 2016. PMID: 27526682 Free PMC article. Clinical Trial.

7

A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells.

Xu Y, Shan W, Li X, Wang B, Liu S, Wang Y, Long Y, Tie R, Wang L, Cai S, Zhang H, Lin Y, Zhang M, Zheng W, Luo Y, Yu X, Yee JK, Ji J, Huang H. Xu Y, et al. Among authors: huang h. J Hematol Oncol. 2016 Sep 29;9(1):102. doi: 10.1186/s13045-016-0326-6. J Hematol Oncol. 2016. PMID: 27686241 Free PMC article.

8

Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia.

Wei G, Ding L, Wang J, Hu Y, Huang H. Wei G, et al. Among authors: huang h. Exp Hematol Oncol. 2017 Apr 14;6:10. doi: 10.1186/s40164-017-0070-9. eCollection 2017. Exp Hematol Oncol. 2017. PMID: 28413717 Free PMC article. Review.

9

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.

Santoro N, Ruggeri A, Labopin M, Bacigalupo A, Ciceri F, Gülbaş Z, Huang H, Afanasyev B, Arcese W, Wu D, Koc Y, Tischer J, Santarone S, Giebel S, Mohty M, Nagler A. Santoro N, et al. Among authors: huang h. J Hematol Oncol. 2017 May 30;10(1):113. doi: 10.1186/s13045-017-0480-5. J Hematol Oncol. 2017. PMID: 28558762 Free PMC article.

10

Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia.

Wei G, Wang J, Huang H, Zhao Y. Wei G, et al. Among authors: huang h. J Hematol Oncol. 2017 Aug 18;10(1):150. doi: 10.1186/s13045-017-0516-x. J Hematol Oncol. 2017. PMID: 28821272 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,936 results

Search Page